Low rates of #locoregionalrecurrence in patients with clinical stage IIB #breastcancer who undergo #neoadjuvanttherapy (NAT) and #mastectomy have been reported, but risk factors have not been quantified. Read more in Medicine®: https://t.co/LqbqeNXT2q h…
Low rates of #locoregionalrecurrence in patients with clinical stage IIB #breastcancer who undergo #neoadjuvanttherapy and #mastectomy have been reported. Read more in Medicine®: https://t.co/K8oLkleUpi https://t.co/aa7VncCZAf
Current Issue: Locoregional Outcomes in Clinical Stage IIB Breast Cancer After Neoadjuvant Therapy and Mastect... http://t.co/10vJvFBp6x